Client Login

Insights

Discover our latest research, perspectives, and industry insights


The GLP-1 Revolution: What Expanding Indications Means for Employers in 2026

The GLP-1 Revolution: What Expanding Indications Means for Employers in 2026

We are at the beginning of a broader therapeutic transition as clinicians recognized that GLP-1 medications influence much more than blood sugar alone.

December 11, 2025Keywords
glp-1
type 2 diabetes
pharmacy
weight reduction
injectables
wegovy

More Insights